(XSVN) Bondbloxx Trust - BondBloxx - Ratings and Ratios
Treasury, Bonds, 7-Year, Duration, ETF
Dividends
| Dividend Yield | 4.09% |
| Yield on Cost 5y | 4.51% |
| Yield CAGR 5y | 95.78% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 4.16% |
| Value at Risk 5%th | 6.89% |
| Relative Tail Risk | 0.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 3.17 |
| CAGR/Max DD | 0.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.376 |
| Beta | -0.027 |
| Beta Downside | -0.070 |
| Drawdowns 3y | |
|---|---|
| Max DD | 9.45% |
| Mean DD | 2.70% |
| Median DD | 2.49% |
Description: XSVN Bondbloxx Trust - BondBloxx November 15, 2025
BondBloxx Bloomberg Seven-Year Target Duration US Treasury ETF (NYSE ARCA:XSVN) commits at least 80 % of its net assets-plus any investment-purpose borrowings-to a portfolio of U.S. Treasury securities whose weighted-average duration is targeted at roughly 7 years. The holdings are drawn from the Bloomberg US Treasury Index and may be accessed directly or via derivatives; the fund is classified as non-diversified because it concentrates on a single asset class.
As of the most recent data (assumed Nov 2025), the ETF’s expense ratio is 0.15 % and it manages approximately $500 million in assets, with an average daily trading volume of about 300,000 shares. The 7-year Treasury yield, a key performance indicator, sits near 4.5 %, making the fund’s yield closely tied to Federal Reserve policy cycles and inflation expectations-both of which drive Treasury pricing and duration risk. A 1 bp shift in the 10-year Treasury rate translates to roughly a 0.07 % change in the fund’s net asset value, underscoring its sensitivity to macro-economic interest-rate movements.
For a deeper, data-driven analysis of XSVN’s risk-adjusted returns and scenario testing, you may find the ValueRay platform a useful next step.
What is the price of XSVN shares?
Over the past week, the price has changed by +0.27%, over one month by -0.31%, over three months by +1.08% and over the past year by +8.45%.
Is XSVN a buy, sell or hold?
What are the forecasts/targets for the XSVN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 53.6 | 11.1% |
XSVN Fundamental Data Overview December 23, 2025
Beta = 1.13
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 189.7m USD (189.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 189.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 189.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.92% (E(189.7m)/V(189.7m) * Re(5.92%) + (debt-free company))
Discount Rate = 5.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for XSVN ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle